SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects

PART 1 \& 2 (Healthy Volunteers) Inclusion Criteria: * Healthy male subjects and female subjects of NOCBP. * Between 18 and 55 years of age (Part 1) and 30 and 55 years of age (Part 2), inclusive. * A body mass index of between 18.0 and 32.0 kg/m2, inclusive. * Contraception requirements for male \& female subjects. Exclusion Criteria: * Known hypersensitivity or allergy to AMT-126 or excipient contained in the drug formulation. * Clinically significant abnormalities in laboratory test results (including complete blood count, chemistry panel including kidney panel, and urinalysis). * Presence, or history of clinically significant disease which requires treatment, as judged by the investigator. * Evidence of current SARS-CoV-2 or COVID infection. * Women of child-bearing potential.